References

  1. WHO Report. Global update on HIV treatment 2013: Results, Impact and Opportunities. http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/unaidspublication/2013/20130630_treatment_report_en.pdf (accessed 3 Apr 2015). Google Scholar

  2. Mocroft A, Lundgren JD, Sabin ML et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013; 10(9): e1001510. PubMed | Google Scholar

  3. Helleberg M, Engsig FN, Kronborg G et al. Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis. 2012; 44(4): 282-8. PubMed | Google Scholar

  4. Antinori A, Coenen T, Costagiola D et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011; 12(1): 61-4. PubMed | Google Scholar

  5. Lawn SD, Harries AD, Anglaret X et al. Early mortality among adults accessing antiretroviral treatment programs in sub-Saharan Africa. AIDS Lond Engl. 2008; 22(15): 1897-908. PubMed | Google Scholar

  6. Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 < 200 cells/microL) with HIV infection. HIV Med. 2004; 5(2): 93-8. PubMed | Google Scholar

  7. Nash D, Katyal M, Brinkhof MWG et al. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS Lond Engl. 2008; 22(17): 2291-302. PubMed | Google Scholar

  8. Robbins GK, Spritzler JG, Chan ES et al. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009; 48(3): 350-61. PubMed | Google Scholar

  9. Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6): 493-505. PubMed | Google Scholar

  10. Marks G, Crepaz N, Senterfitt JW et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 1999. 2005; 39(4): 446-53. PubMed | Google Scholar

  11. Hønge BL, Jespersen S, Nordentoft PB et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open. 2013; 3(10): e003499. PubMed | Google Scholar

  12. Marcellin F, Abé C, Loubière S et al. Delayed first consultation after diagnosis of HIV infection in Cameroon. AIDS Lond Engl. 2009; 23(8): 1015-9. PubMed | Google Scholar

  13. Lahuerta M, Wu Y, Hoffman S et al. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014; 58(3): 432-41. PubMed | Google Scholar

  14. Da Silva ZJ, Oliveira I, Andersen A et al. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS Lond Engl. 2008; 22(10): 1195-202. PubMed | Google Scholar

  15. Rowland-Jones SL, Whittle HC. Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? Nat Immunol. 2007; 8(4): 329-31. PubMed | Google Scholar

  16. Campbell-Yesufu OT, Gandhi RT. Update on Human Immunodeficiency Virus (HIV)-2 Infection. Clin Infect Dis. 2011; 52(6): 780-7. PubMed | Google Scholar

  17. Oliveira I, Andersen A, Furtado A et al. Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study. BMJ Open. 2012; 2(6): e001587. PubMed | Google Scholar

  18. Jespersen S, Honge BL, Oliveira I et al. Cohort Profile: The Bissau HIV Cohort--a cohort of HIV-1, HIV-2 and co-infected patients. Int J Epidemiol. 2015 Jun; 44(3): 756-63. PubMed | Google Scholar

  19. Mugglin C, Estill J, Wandeler G et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health TM IH. 2012; 17(12): 1509-20. PubMed | Google Scholar

  20. Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PloS One. 2009; 4(6): e5790. PubMed | Google Scholar

  21. Hønge BL, Bjarnason Obinah MP, Jespersen S et al. Performance of 3 rapid tests for discrimination between HIV-1 and HIV-2 in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr 1999. 2014; 65(1): 87-90. PubMed | Google Scholar

  22. Hønge BL, Jespersen S, Pétur Bjarnason MO et al. Inter-observer variation of the rapid test SD Bioline HIV 1/2 3 0 for HIV type discrimination: experiences from Guinea-Bissau. J Acquir Immune Defic Syndr. 2015 Feb 1; 68(2): e23-5. PubMed | Google Scholar

  23. Sabin CA, Smith CJ, Gumley H et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS Lond Engl. 2004; 18(16): 2145-51. PubMed | Google Scholar

  24. Adler A, Mounier-Jack S, Coker RJ. Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care. 2009; 21(3): 284-93. PubMed | Google Scholar

  25. Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo ZoneEthiopia: a case-control study. AIDS Res Ther. 2011 Feb 28; 8: 8. PubMed | Google Scholar

  26. Zango A, Dubé K, Kelbert S et al. Determinants of prevalent HIV infection and late HIV diagnosis among young women with two or more sexual partners in Beira, Mozambique. PloS One. 2013; 8(5): e63427. PubMed | Google Scholar

  27. Drain PK, Losina E, Parker G et al. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PloS One. 2013; 8(1): e55305. PubMed | Google Scholar

  28. Kigozi IM, Dobkin LM, Martin JN et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009 Oct 1; 52(2): 280-9. PubMed | Google Scholar

  29. Jespersen S, Hønge BL, Esbjörnsson J et al. Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse off. Trop Med Int Health. 2016; 21(2): 253-62. PubMed | Google Scholar

  30. Jespersen S, Hønge BL, Oliveira I et al. Challenges facing HIV treatment in Guinea-Bissau: the benefits of international research collaborations. Bull World Health Organ. 2014; 92(12): 909-14. PubMed | Google Scholar

  31. Wynberg E, Cooke G, Shroufi A et al. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc. 2014 Jan 20; 17: 18809. PubMed | Google Scholar

  32. Rowley CF. Developments in CD4 and viral load monitoring in resource-limited settings. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014; 58(3): 407-12. PubMed | Google Scholar

  33. Chaillet P, Tayler-Smith K, Zachariah R et al. Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa. Trans R Soc Trop Med Hyg. 2010; 104(9): 571-6. PubMed | Google Scholar

  34. Esbjörnsson J, Månsson F, Kvist A et al. Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection. N Engl J Med. 2012; 367(3): 224-32. PubMed | Google Scholar

  35. Esbjörnsson J, Månsson F, Kvist A et al. Effect of HIV-2 infection on HIV-1 disease progression and mortality. AIDS Lond Engl. 2014; 28(4): 614-5. PubMed | Google Scholar

  36. Prince PD, Matser A, van Tienen C et al. Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and meta-analysis. AIDS Lond Engl. 2014; 28(4): 549-58. PubMed | Google Scholar

  37. Siedner MJ, Ng CK, Bassett IV et al. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015; 60(7): 1120-7. PubMed | Google Scholar

  38. Aaby P, Bukh J, Lisse IM et al. Spacing, crowding, and child mortality in Guinea-Bissau. Lancet. 1983; 2(8342): 161. PubMed | Google Scholar

  39. Fisker AB, Aaby P, Bale C et al. Does the effect of vitamin A supplements depend on vaccination status? An observational study from Guinea-Bissau. BMJ Open. 2012; 2(1): e000448. PubMed | Google Scholar

  40. Fazzio I, Mann V, Boone P. Temporal trends (1977-2007) and ethnic inequity in child mortality in rural villages of southern Guinea Bissau. BMC Public Health. 2011 Sep 2; 11: 683. PubMed | Google Scholar

  41. Quattrochi J, Jasseh M, Mackenzie G et al. Spatial analysis of under-5 mortality and potential risk factors in the Basse Health and Demographic Surveillance System, the Gambia. Trop Med Int Health. 2015 Jul; 20(7): 941-51. PubMed | Google Scholar

  42. Mane M, Fisker AB, Ravn H et al. Trends and determinants of mortality in women of reproductive age in rural Guinea-Bissau, West Africa--a cohort study. BMC Womens Health. 2013 Dec 5; 13: 48. PubMed | Google Scholar

  43. Gianelli E, Riva A, Rankin Bravo FA et al. Prevalence and risk determinants of HIV-1 and HIV-2 infections in pregnant women in Bissau. J Infect. 2010; 61(5): 391-8. PubMed | Google Scholar

  44. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua=1 (accessed 3 Apr 2015). Google Scholar